The dual-layer platform can identify malicious instructions from a host computer.
Medical imaging devices could have a new option for cybersecurity protection that could also help eliminate human- and system-related errors.
With its dual-layer architecture, this new technique can pick up on potentially dangerous instructions that are transmitted to a medical device from a host computer. According to researchers, the system can detect up to 99 percent of abnormal information in CT systems.
Ben-Gurion University Ph.D. candidate Tom Mahler and his colleagues presented this work at the 2020 International Conference on Artificial Intelligence in Medicine on Aug. 26.
Related Content: The Importance of Cybersecurity in This Era of Radiology
According to Mahler, CT, MRI, and ultrasound machines are controlled by directions provided by a host computer. But, they can be infiltrated and compromised by cyberattacks, human errors, or software bugs. When this happens, they are vulnerable to receiving malicious instructions that can lead to radiation over-exposure, manipulation of device components, and image alteration.
To side-step these problems, Mahler and his team created a cybersecurity tool with a dual-layer architecture that can detect two types of anomalous instructions. They can be either context-free (CF) instructions that are unlikely values or directives, such as a 100-times increase in radiation dose, or context-sensitive (CS) instructions that are normal values or value combinations that could result in a mismatch of intended scan type, patient age, weight, or potential diagnosis. These types of situations can create patient harm, he said.
“For example, a normal instruction intended for an adult might be dangerous [anomalous] if applied to an infant,” he said. “Such instructions may be misclassified when using only the first, CF, layer; however, by adding the second, CS layer, they can now be detected.”
Mahler’s team tested and analyzed their new architecture on a CT system with 8,277 recorded CT instructions. They, then, evaluated the CS layer for four different types of clinical objective contexts, employing five supervised classification algorithms for each context. Adding the second CS layer, they said, boosted the overall anomaly detection performance to between 82 percent and 99 percent from 71.6 percent with just the CF layer.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.